IONS
Ionis Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
4.41 / 10
Netural
Financial evaluation of Ionis Pharmaceuticals yields a score of 4.4/10, indicating fair but imperfect fundamentals. Key strengths include a solid interest-coverage ratio (15.48%) and positive Profit-MV, both contributing to a selective buy stance. However, challenges such as high Days Sales Outstanding (72.55) and moderate revenue growth (54.71% YoY) temper enthusiasm. Overall, the company's financial structure is stable yet not exceptional, warranting a cautious, selective approach.
Analysis Checks(6/10)
Revenue-MV
Value-1.89
Score1/3
Weight8.11%
1M Return4.24%
Value-1.89
Score1/3
Weight8.11%
1M Return4.24%
Days sales outstanding
Value72.55
Score1/3
Weight-2.22%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.22%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight16.13%
1M Return8.45%
Value-0.17
Score2/3
Weight16.13%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.61%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.61%
1M Return-1.11%
Asset-MV
Value-0.50
Score3/3
Weight29.87%
1M Return13.15%
Value-0.50
Score3/3
Weight29.87%
1M Return13.15%
Total operating revenue (YoY growth rate %)
Value54.71
Score1/3
Weight-1.18%
1M Return-0.79%
Value54.71
Score1/3
Weight-1.18%
1M Return-0.79%
Profit-MV
Value0.46
Score2/3
Weight16.11%
1M Return8.45%
Value0.46
Score2/3
Weight16.11%
1M Return8.45%
PB-ROE
Value2.38
Score2/3
Weight20.09%
1M Return9.14%
Value2.38
Score2/3
Weight20.09%
1M Return9.14%
Operating revenue (YoY growth rate %)
Value54.71
Score1/3
Weight-1.14%
1M Return-0.76%
Value54.71
Score1/3
Weight-1.14%
1M Return-0.76%
Cash-MV
Value-0.07
Score2/3
Weight15.84%
1M Return8.41%
Value-0.07
Score2/3
Weight15.84%
1M Return8.41%
Revenue-MV
Value-1.89
Score1/3
Weight8.11%
1M Return4.24%
Value-1.89
Score1/3
Weight8.11%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value54.71
Score1/3
Weight-1.18%
1M Return-0.79%
Value54.71
Score1/3
Weight-1.18%
1M Return-0.79%
Days sales outstanding
Value72.55
Score1/3
Weight-2.22%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.22%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight16.11%
1M Return8.45%
Value0.46
Score2/3
Weight16.11%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight16.13%
1M Return8.45%
Value-0.17
Score2/3
Weight16.13%
1M Return8.45%
PB-ROE
Value2.38
Score2/3
Weight20.09%
1M Return9.14%
Value2.38
Score2/3
Weight20.09%
1M Return9.14%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.61%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.61%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value54.71
Score1/3
Weight-1.14%
1M Return-0.76%
Value54.71
Score1/3
Weight-1.14%
1M Return-0.76%
Asset-MV
Value-0.50
Score3/3
Weight29.87%
1M Return13.15%
Value-0.50
Score3/3
Weight29.87%
1M Return13.15%
Cash-MV
Value-0.07
Score2/3
Weight15.84%
1M Return8.41%
Value-0.07
Score2/3
Weight15.84%
1M Return8.41%
Is IONS fundamentally strong?
- IONS scores 4.41/10 on fundamentals and holds a Fair valuation at present. Backed by its -25.20% ROE, -26.51% net margin, -54.66 P/E ratio, 22.67 P/B ratio, and 34.02% earnings growth, these metrics solidify its Netural investment rating.
